GOLDSMITH MARK A sold RVMD
August 21, 2026 · Form 4 insider transaction
GOLDSMITH MARK A sold 35,938 shares of Revolution Medicines, Inc. at $209.26 per share, a transaction worth $7.52M. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 4 days after the transaction.
Footnotes
Transaction made pursuant to a 10b5-1 trading plan adopted by Mark A. Goldsmith on May 22, 2026.; This transaction was executed in multiple trades at prices ranging from $208.80 to $209.78. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.; Includes 182,938 restricted stock units.